References
- Aiko, V., & Mehta, A. (2015). Occurrence, detection and detoxification of mycotoxins. Journal of Biosciences, 40(5), 943–954. doi: https://doi.org/10.1007/s12038-015-9569-6
- Belkaid, Y., & Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell, 157(1), 121–141. doi: https://doi.org/10.1016/j.cell.2014.03.011
- Bennett, J. W., & Klich, M. (2003). Mycotoxins. Clinical Microbiology Reviews, 16(3), 497–516. doi: https://doi.org/10.1128/CMR.16.3.497-516.2003
- Biehl, M. L., Prelusky, D. B., Koritz, G. D., Hartin, K. E., Buck, W. B., & Trenholm, H. L. (1993). Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicology & Applied Pharmacology, 121(1), 152–159. doi: https://doi.org/10.1006/taap.1993.1140
- Bouhet, S., & Oswald, I. P. (2005). The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Veterinary Immunology & Immunopathology, 108(1–2), 199–209. doi: https://doi.org/10.1016/j.vetimm.2005.08.010
- Chassard, C., Dapoigny, M., Scott, K. P., Crouzet, L., Del’Homme, C., Marquet, P., … Eschalier, A. (2012). Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 35(7), 828–838. doi: https://doi.org/10.1111/j.1365-2036.2012.05007.x
- Choung, R. S., & Locke, G. R. (2011). Epidemiology of IBS. Gastroenterology Clinics of North America, 40(1), 1–10. doi: https://doi.org/10.1016/j.gtc.2010.12.006
- Compare, D., & Nardone, G. (2014). The role of gut microbiota in the pathogenesis and management of allergic diseases. European Review for Medical & Pharmacological Sciences, 18(17), 11–17.
- D’Aversa, F., Tortora, A., Ianiro, G., Ponziani, F. R., Annicchiarico, B. E., & Gasbarrini, A. (2013). Gut microbiota and metabolic syndrome. Internal & Emergency Medicine, 8(1), 11–15. doi: https://doi.org/10.1007/s11739-013-0916-z
- Derrien, M., & van Hylckama Vlieg, J. E. T. (2015). Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends in Microbiology, 23(6), 354–366. doi: https://doi.org/10.1016/j.tim.2015.03.002
- Desantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., … Andersen, G. L. (2006). Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Applied & Environmental Microbiology, 72(7), 5069–5072. doi: https://doi.org/10.1128/AEM.03006-05
- Edgar, R. C. (2013). UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nature Methods, 10(10), 996–998. doi: https://doi.org/10.1038/nmeth.2604
- Edgar, R. C., Haas, B. J., Clemente, J. C., Christopher, Q., & Rob, K. (2011). UCHIME improves sensitivity and speed of chimera detection. Bioinformatics, 27(16), 2194–2200. doi: https://doi.org/10.1093/bioinformatics/btr381
- Fan, W. T., Ding, C., Xu, N. N., Zong, S., Ma, P., & Gu, B. (2017). Close association between intestinal microbiota and irritable bowel syndrome. European Journal of Clinical Microbiology & Infectious Diseases Official Publication of the European Society of Clinical Microbiology, 36(1), 1–15. doi: https://doi.org/10.1007/s10096-016-2778-6
- Gajęcka, M., Zielonka, Ł, & Gajęcki, M. (2017). Activity of zearalenone in the porcine intestinal tract. Molecules, 22(1), 18. doi: https://doi.org/10.3390/molecules22010018
- Horai, R., Zárate-Bladés, C., Dillenburg-Pilla, P., Chen, J., Kielczewski, J., Silver, P., … Honda, K. (2015). Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity, 43(2), 343–353. doi: https://doi.org/10.1016/j.immuni.2015.07.014
- Hullar, M. A. J., Burnett-Hartman, A. N., & Lampe, J. W. (2014). Gut microbes, diet, and cancer. Cancer Treatment & Research, 159, 377–399. doi: https://doi.org/10.1007/978-3-642-38007-5_22
- Kabeerdoss, J., Sankaran, V., Pugazhendhi, S., & Ramakrishna, B. S. (2013). Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: A case–control study in India. Bmc Gastroenterology, 13(1), 20–20. doi: https://doi.org/10.1186/1471-230X-13-20
- Kato, L. M., Kawamoto, S., Maruya, M., & Fagarasan, S. (2014). Gut TFH and IgA: Key players for regulation of bacterial communities and immune homeostasis. Immunology & Cell Biology, 92(1), 49–56. doi: https://doi.org/10.1038/icb.2013.54
- Kiang, D. T., Kennedy, B. J., Pathre, S. V., & Mirocha, C. J. (1978). Binding characteristics of zearalenone analogs to estrogen receptors. Cancer Research, 38(11 Pt 1), 3611.
- Kuiper-Goodman, T., Scott, P. M., & Watanabe, H. (1987). Risk assessment of the mycotoxin zearalenone. Regulatory Toxicology & Pharmacology, 7(3), 253–306. doi: https://doi.org/10.1016/0273-2300(87)90037-7
- Liu, M., Gao, R., Meng, Q., Zhang, Y., Bi, C., & Shan, A. (2014). Toxic effects of maternal zearalenone exposure on intestinal oxidative stress, barrier function, immunological and morphological changes in rats. PLoS ONE, 9(9), e106412. doi: https://doi.org/10.1371/journal.pone.0106412
- Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods, 25(4), 402–408. doi: https://doi.org/10.1006/meth.2001.1262
- Macpherson, A. J., Slack, E., Geuking, M. B., & Mccoy, K. D. (2009). The mucosal firewalls against commensal intestinal microbes. Seminars in Immunopathology, 31(2), 145–149. doi: https://doi.org/10.1007/s00281-009-0174-3
- Magoč, T., & Salzberg, S. L. (2011). FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics, 27(21), 2957–2963. doi: https://doi.org/10.1093/bioinformatics/btr507
- Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., … Marteau, P. (2006). Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Digest of the World Core Medical Journals, 55(2), 205–211.
- Mantis, N. J., Rol, N., & Corthésy, B. (2011). Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunology, 4(6), 603–611. doi: https://doi.org/10.1038/mi.2011.41
- Maresca, M., & Fantini, J. (2010). Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. Toxicon, 56(3), 282–294. doi: https://doi.org/10.1016/j.toxicon.2010.04.016
- Martín, R., Miquel, S., Ulmer, J., Kechaou, N., Langella, P., & Bermúdez-Humarán, L. G. (2013). Role of commensal and probiotic bacteria in human health: A focus on inflammatory bowel disease. Microbial Cell Factories, 12(1), 71–71. doi: https://doi.org/10.1186/1475-2859-12-71
- Molloy, M. J., Bouladoux, N., & Belkaid, Y. (2012). Intestinal microbiota: Shaping local and systemic immune responses. Seminars in Immunology, 24(1), 58–66. doi: https://doi.org/10.1016/j.smim.2011.11.008
- Ojeda, P., Bobe, A., Dolan, K., Leone, V., & Martinez, K. (2016). Nutritional modulation of gut microbiota — the impact on metabolic disease pathophysiology. Journal of Nutritional Biochemistry, 28, 191–200. doi: https://doi.org/10.1016/j.jnutbio.2015.08.013
- Okumura, R., & Takeda, K. (2018). Maintenance of intestinal homeostasis by mucosal barriers. Inflammation & Regeneration, 38(1), G1168. doi: https://doi.org/10.1186/s41232-018-0063-z
- Phillips, M. L. (1900). Reacción visceral: Efectos ambientales sobre la microbiota humana. Salud Pública De México, 51(4), 343–352. doi: https://doi.org/10.1590/S0036-36342009000400012
- Quigley, E. M. (2013). Gut bacteria in health and disease. Gastroenterology & Hepatology, 9(9), 560.
- Seonghwan, P., Hyejin, C., Yang, H., Keehun, D., Juil, K., & Yuseok, M. (2010). Repression of peroxisome proliferator-activated receptor γ by mucosal ribotoxic insult-activated CCAAT/enhancer-binding protein homologous protein. Journal of Immunology, 185(9), 5522–5530. doi: https://doi.org/10.4049/jimmunol.1001315
- Shen, S., & Wong Connie, H. Y. (2016). Bugging inflammation: Role of the gut microbiota. Clinical & Translational Immunology, 5(4), e72. doi: https://doi.org/10.1038/cti.2016.12
- Sun, J., & Chang, E. B. (2014). Exploring gut microbes in human health and disease: Pushing the envelope. Genes & Diseases, 1(2), 132–139. doi: https://doi.org/10.1016/j.gendis.2014.08.001
- Urara, N., & Hiroya, K. (2015). The nonsteroidal mycoestrogen zearalenone and its five metabolites suppress LH secretion from the bovine anterior pituitary cells via the estradiol receptor GPR30 in vitro. Theriogenology, 84(8), 1342–1349. doi: https://doi.org/10.1016/j.theriogenology.2015.07.014
- Wan, L. Y. M., Allen, K. J., Turner, P. C., & El-Nezami, H. (2014). Modulation of mucin mRNA (MUC5AC and MUC5B) expression and protein production and secretion in caco-2/HT29-MTX Co-cultures following exposure to individual and combined fusarium mycotoxins. Toxicological Sciences, 139(1), 83–98. doi: https://doi.org/10.1093/toxsci/kfu019
- Wan, L. Y. M., Woo, C. S. J., Turner, P. C., Wan, M. F., & El-Nezami, H. (2013). Individual and combined effects of fusarium toxins on the mRNA expression of pro-inflammatory cytokines in swine jejunal epithelial cells. Toxicology Letters, 220(3), 238–246. doi: https://doi.org/10.1016/j.toxlet.2013.05.003
- Wan, M. L., Woo, C. S., Allen, K. J., Turner, P. C., & El-Nezami, H. (2013). Modulation of porcine β-defensins 1 and 2 upon individual and combined fusarium toxin exposure in a swine jejunal epithelial cell line. Applied & Environmental Microbiology, 79(7), 2225–2232. doi: https://doi.org/10.1128/AEM.03277-12